Loading…

Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome

At the end of 1989 a new disease called eosinophiliamyalgia syndrome (EMS) appeared in America and West Germany. Epidemiologic investigators traced the cause to an unknown contaminant in L-tryptophan (LT) dietary supplement tablets. Of the more than 50 contaminants found in the LT material by high-p...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of environmental contamination and toxicology 1992-05, Vol.48 (5), p.679-687
Main Authors: DRISKELL, W. J, ASHLEY, D. L, GRAINGER, J, SIRIMANNE, S. R, MAZZOLA, E. P, PAGE, S. W, NEEDHAM, L. L, HILL, R. H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:At the end of 1989 a new disease called eosinophiliamyalgia syndrome (EMS) appeared in America and West Germany. Epidemiologic investigators traced the cause to an unknown contaminant in L-tryptophan (LT) dietary supplement tablets. Of the more than 50 contaminants found in the LT material by high-performance liquid chromatography (HPLC) analysis, a contaminant identified as 1,1'-ethylidenebis (L-tryptophan) (EBT), also known as "peak 97" and "peak E", was the only one that had a marked association with EMS cases. In this report we describe studies in which we incubated EBT in simulated gastric fluid, followed the course of its breakdown into other products, and identified all of those products.
ISSN:0007-4861
1432-0800
DOI:10.1007/BF00195987